SOPHiA GENETICS
Healthcare Software · Switzerland · 201-500 Employees
View Company Info for Free
Overview
Headquarters
La Piece 12, Rolle, Vaud, 1180, Switzerl...Phone Number
+41 216941060Website
www.sophiagenetics.comRevenue
$64.9 MillionStock Symbol
SOPHIndustry
ZI Rank: 2
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
3
5
2
2
1
2
About SOPHiA GENETICS
SOPHiA GENETICS is a data-driven medicine company that uses statistical inference, pattern recognition and machine learning for genomics and radiomics data to support the healthcare industry. SOPHiA GENETICS, headquartered in Saint-Sulpice, Switzerland, is used by geneticists, pathologists and radiologists in hospitals.Explore more
SOPHiA GENETICS Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is SOPHiA GENETICS your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once SOPHiA GENETICS has new funding data
Check if SOPHiA GENETICS has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at SOPHiA GENETICS
Click to see if SOPHiA GENETICS had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if SOPHiA GENETICS is spiking on competitors!
SOPHiA GENETICS, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when SOPHiA GENETICS launches new products
Earning: See what the market has to say on SOPHiA GENETICS recently announced quarterly report
Website visits: Recent activity has been detected on your website
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Company Profile Activity
Activity Insights
SOPHiA GENETICS is experiencing very low activity levels compared to other companies in the Software sector.
What does this means?
SOPHiA GENETICS is drawing exceptional interest within the Software industry, suggesting notable developments or strong market momentum, learn more about SOPHiA GENETICS.
SOPHiA GENETICS financials insights
Gather financial insights about SOPHiA GENETICS, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2013
Series A
$3M
2014
Series B
$13.8M
2015
Series C
$15M
2017
Series D
$30M
2019
Series E
$77M
2020
Series F
$110M
2021
Share Placement
$234M
SOPHiA GENETICS Tech Stack
A closer look at the technologies used by SOPHiA GENETICS
See more technologies
Most Recent Scoops
Person-Based
Business Development, Contracts
Person-Based
Earnings, Financial Reporting, Finance
Hiring Plans
SOPHiA GENETICS has more open roles in Marketing than it has had at any time in the past 12 months with an increased focus on technologies like Google Marketing Platform, Google Ads, Salesforce, and Google Analytics, and experience with YouTube.
Hiring Plans
Open Position
Open Position
SOPHiA GENETICS News & Media
SOPHiA GENETICS (SOPH) CTO trades 5000 shares under Rule 10b5-1 plan - Stock Titan
CTO Abhimanyu Verma sold 5,000 SOPHiA GENETICS shares at a weighted average of $6.9543 on 2026-08-04 under a Rule 10b5-1 plan, retaining 187,171 shares.SOPHiA GENETICS SA (SOPH) Q2 2026 Earnings Call Transcript
SOPHiA GENETICS SA (SOPH) Q2 2026 Earnings Call August 4, 2026 8:00 AM EDTCompany ParticipantsKellen Sanger - Head of Strategy and Investor RelationsRoss...SOPHiA GENETICS Reports Second Quarter 2026 Results
BOSTON and ROLLE, Switzerland, Aug. 4, 2026 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a global leader in AI-driven precision medicine, today reported financial results for the second quarter ended June 30, 2026. Second Quarter 2026 Financial Highlights Revenue was $23.3 million, up...SOPHiA GENETICS Enters Collaboration to Develop Companion Diagnostics for Precision Oncology Therapies
BOSTON and ROLLE, Switzerland, Aug. 4, 2026 /PRNewswire/ -- SOPHiA GENETICS (NASDAQ: SOPH) today announced a new global collaboration to develop, validate, and deploy two companion diagnostics (CDx) supporting precision oncology therapies with AstraZeneca (LSE/STO/NYSE: AZN). This multi-year collaboration agreement will advance the development and commercialization of two companion diagnostic programs, bringing SOPHiA GENETICS's decentralized clinical trial assays and companion diagnostic capabi
Read more news
Top Healthcare Software Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding SOPHiA GENETICS
Sign Up For FreeTo access detailed company insights
SOPHiA GENETICS is a data-driven medicine company that uses statistical inference, pattern recognition and machine learning for genomics and radiomics data to support the healthcare industry. SOPHiA GENETICS, headquartered in Saint-Sulpice, Switzerland, is used by geneticists, pathologists and radiologists in hospitals.... Read More
